Observational studyFrontiers in immunology2026
Epidermal growth factor receptor and myeloperoxidase expression in geographic tongue: an observational study.
Observational study in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Geographic tongue (GT) is a common oral mucosal lesion that affects the dorsal and lateral surfaces of the tongue and characterized by erythematous areas of papillary atrophy surrounded by peripheral zones. The aim of this study was to evaluate the expression of myeloperoxidase (MPO), epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) in tissue samples from patients with GT compared to control. Methods: Biopsies specimens from patients with GT (n=10, mean age 48.3 ± 16.7 years) and control subjects (n=3, mean age 59.0 ± 3 years) were evaluated. Immunofluorescence was used to assess the MPO staining intensity of positive cells (i.e. scoring grades 0, 1 and 2). Furthermore, the percentage of EFG and EGFR positive cells in the tongue tissue samples was evaluated by immunofluorescence. Results: Most of the patients with GT (n=6) scored 2 for MPO expression, demonstrating an increased expression of MPO among GT patients compared to controls ( Conclusion: Patients with GT showed a high MPO activity while low EGFR expression which may explain the underlying inflammatory response and decreased regeneration process in GT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.